Marco Viviani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marco Viviani has a total of 157 co-authors. Here are the top co-authors by number of shared publications:
- Elena Grassi
Candiolo Cancer Institute, FPO-IRCCS
55 shared publications - Livio Trusolino
Laboratory of Translational Cancer Medicine, Candiolo Cancer Institute – FPO IRCCs, Candiolo, Torino, Italy
54 shared publications - Andrea Bertotti
Candiolo Cancer Institute—FPO IRCCS, Torino, Italy
52 shared publications - Barbara Lupo
Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy
50 shared publications - Eugenia Rosalinda Zanella
Candiolo Cancer Institute – FPO IRCCS, Torino, Italy
50 shared publications - Francesca Cottino
Candiolo Cancer Institute – FPO IRCCS, Torino, Italy
50 shared publications
Latest Publications
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Supplementary Table S5 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Supplementary Table S5 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Cell cycle analysis in FOLFIRI-sensitive and resistant PDXs and tumoroids
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Cell cycle analysis in FOLFIRI-sensitive and resistant PDXs and tumoroids
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S15 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
ATM inhibition efficacy in additional PDX models
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S15 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
ATM inhibition efficacy in additional PDX models
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Correlations between FOLFIRI response biomarkers in PDX models
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Correlations between FOLFIRI response biomarkers in PDX models
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
RAD51 as a biomarker of FOLFIRI resistance in PDXs and tumoroids
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
RAD51 as a biomarker of FOLFIRI resistance in PDXs and tumoroids
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Mutational and genomic evaluation of HR gene status in PDX models
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Mutational and genomic evaluation of HR gene status in PDX models
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Differential expression and methylation of HR genes
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Differential expression and methylation of HR genes
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Gene expression differences between FOLFIRI-resistant and FOLFIRI-sensitive tumors in patients from the FIRE-3 trial
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Gene expression differences between FOLFIRI-resistant and FOLFIRI-sensitive tumors in patients from the FIRE-3 trial
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Response annotation of IRIS patients
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Response annotation of IRIS patients
- Open Access
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Results of transcriptional analyses
- 9 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer
Results of transcriptional analyses